期刊文献+

我院2005年临床分离菌菌群分布及耐药分析 被引量:13

Analysis of Bacterial Distribution and Drug Resistance in the 252nd Hospital of PLA in the Year 2005
下载PDF
导出
摘要 目的:了解我院临床分离菌的分布及耐药情况,为指导临床合理用药提供参考依据。方法:采用Vitek-2全自动微生物分析仪及纸片扩散法(Kirby-Bauer)对2 024株分离菌进行鉴定及药敏实验。结果:2 024株分离菌中革兰阴性菌占53.6%,革兰阳性菌占36.0%,真菌占10.4%,金黄色葡萄球菌及凝固酶阴性的葡萄球菌中甲氧西林耐药株各占30.2%和34.4%。革兰阳性球菌中万古霉素抗菌活性最强,粪肠球菌对万古霉素耐药率为1.7%。革兰阴性杆菌中亚胺培南抗菌活性最强,铜绿假单胞菌对其有4.6%的耐药率;大肠埃希菌及肺炎克雷伯菌超广谱β-内酰胺酶的检出率为65.0%和40.0%。结论:本资料对临床治疗及抗生素药物的选用有参考价值。 Objective:To Analyze the bacterial distribution and resistance in the 252nd Hospital so as to advise the dosage in clinical practice. Methods :The identification of bacteria and susceptibility test were performed using automatic bioanalysis-Vitek-2 and Kirby-Bauer methods. Results:Of 2 024 clinical isolates, gram negative organisms accounted for 53.6% , gram positive organisms for 36.0% ,and eumycete for 9.5%. In staphylococuus aureus (MRSA) and coagulase negative Staphylococuus ,MRSA and MRCNS accounted for 30.2% and 34.4% respectively. Vancomycin is the most potent antimicrobial agent against gram positive organisms with the resistant rate of Enterococcus faecalis at 1.7%. Imipenem is the most potent antimicrobial agent against gram negative bacilli with the resistant rate of Pseudomonas aeruginosa at 4.6%. The detection rate of Escherichia coli and Klebsiella pneumonlae were 65.0% and 40. 0% respectively in ESBI.,s. Conclusion : The results can be helpful in reasonable choosing of antimicrobial agents in the treatment of infection caused by pathogenic bacteria.
机构地区 解放军
出处 《华北国防医药》 2007年第1期47-49,共3页 Medical Journal of Beijing Military Region
关键词 革兰氏阳性球菌 革兰氏阴性杆菌 抗药性 细菌 抗生素 Gram positive organisms Gram negative bacilli Drug resistanc, bacteria Antibiotic
  • 相关文献

参考文献10

二级参考文献95

  • 1朱德妹,汪复,胡付品,吴湜,张婴元.2002年上海地区医院细菌耐药性监测[J].中华传染病杂志,2004,22(3):154-159. 被引量:63
  • 2熊自忠,朱德妹,汪复,张婴元.CTX-M-14和CTX-M-24编码基因的检测及其功能表达[J].中华医学杂志,2004,84(17):1454-1459. 被引量:15
  • 3张天托,唐英春,文博,张扣兴,朱家馨,饶宪.临床分离菌对19种常用抗菌药物的耐药性监测[J].中国抗生素杂志,1997,22(1):45-48. 被引量:32
  • 4Perlade DE Smulian AG Cushion MT.Molecular epidemiology and anti-biotic susceptible of Enterococci in Cincinnati, Ohio:a prospective cityside surgery[J].J Clin Microbiol,1997,35(9):2342-2342.
  • 5Walter R Wilson Merle A.Sande.Diagnosis or treatment in infectious diseases.1 st ed.(international edition),McGraw—Hill[M].北京,人民卫生出版社,2001.315-316.
  • 6尹有宽 庞茂银 匡晓芳等.头孢硫脒治疗急性细菌感染27例疗效观察[J].中国抗生素杂志,2003,28(4):254-254.
  • 7廖增顺 李建国 何剑峰.头孢硫脒治疗呼吸系统感染30例[J].中国抗生素杂志,2003,28(4):253-253.
  • 8李玮 胡志亮 张树杰 等.头孢硫脒在胸外科术后的应用.中国抗生素杂志,2003,28(4):256-256.
  • 9[1]CDC, National Nosocomial Infections Surveillance(NNIS) System report, Data summary from October 1986-April 1998; issyed June 1998[J]. Am J Infect Control, 1998,26: 522-533
  • 10[2]Gales AC, Jones RN, Turnidge J, et al. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999[J].Clin Infect Dis,2001,32(Suppl 2): 146-155

共引文献519

同被引文献94

引证文献13

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部